S&P 500   4,618.03 (+0.30%)
DOW   36,351.47 (+0.29%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)
S&P 500   4,618.03 (+0.30%)
DOW   36,351.47 (+0.29%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)
S&P 500   4,618.03 (+0.30%)
DOW   36,351.47 (+0.29%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)
S&P 500   4,618.03 (+0.30%)
DOW   36,351.47 (+0.29%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)

EV Biologics (YECO) Stock Price, News & Analysis

$0.99
0.00 (0.00%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.99
▼
$0.99
50-Day Range
$0.70
▼
$1.50
52-Week Range
$0.70
▼
$2.34
Volume
100 shs
Average Volume
1,243 shs
Market Capitalization
$10.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest

YECO stock logo

About EV Biologics Stock (OTCMKTS:YECO)

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

YECO Stock Price History

YECO Stock News Headlines

December 1, 2023 | americanbankingnews.com
EV Biologics, Inc. (OTCMKTS:YECO) Sees Large Drop in Short Interest
October 17, 2023 | reuters.com
Chinese EV startup WM Motor files for pre-restructuring
December 11, 2023 | Edge On The Street (Ad)
U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
October 4, 2023 | finanznachrichten.de
EV Biologics Corporation: EV Biologics Updates on Funding and Sales
October 2, 2023 | finance.yahoo.com
EV Biologics Updates on Funding and Sales
August 16, 2023 | finance.yahoo.com
EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic
August 7, 2023 | finance.yahoo.com
EV Biologics Appoints Senior Investment Banker as Corporate Finance Director
August 3, 2023 | money.usnews.com
How the New EV Tax Credit Will Affect Your Auto Loan
December 11, 2023 | Edge On The Street (Ad)
U.S. Military Defense Fails Without Vanadium?
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
August 2, 2023 | finanznachrichten.de
EV Biologics Corporation: EV Biologics Hires Senior Chief Financial Officer
August 2, 2023 | finance.yahoo.com
EV Biologics Hires Senior Chief Financial Officer
July 30, 2023 | news.yahoo.com
Toyota is planning a new EV with a 900-mile range and 10-minute charging time: ‘The holy grail of battery vehicles’
July 16, 2023 | usatoday.com
Are you a gas guzzler? The government might try to persuade you to switch to an EV
June 21, 2023 | usatoday.com
How reliable are public EV charging stations? Report shows many EV drivers have issues
May 27, 2023 | finance.yahoo.com
EV Biologics, Inc. (YECO)
May 17, 2023 | finanznachrichten.de
EV Biologics Corporation: EV Biologics Signs Exclusive Distribution Agreement for South America
May 15, 2023 | finance.yahoo.com
EV Biologics Signs Exclusive Distribution Agreement for South America
May 11, 2023 | benzinga.com
Best EV Penny Stocks
April 30, 2023 | washingtonpost.com
GM to scrap Chevy Bolt, its most popular and least expensive EV
March 19, 2023 | a.msn.com
Tesco EV charging network reaches 600 UK stores – and rapid chargers go live
February 21, 2023 | finanznachrichten.de
EV Biologics Corporation: EV Biologics Generates Mesenchymal Stem Cell Lines
February 21, 2023 | finance.yahoo.com
EV Biologics Generates Mesenchymal Stem Cell Lines
January 3, 2023 | finanznachrichten.de
EV Biologics Corporation: EV Biologics Updates on Excyte Subsidiary Funding
January 3, 2023 | finance.yahoo.com
EV Biologics Updates on Excyte Subsidiary Funding
January 2, 2023 | cnet.com
The Best Tires for Your EV Have 4 Unique Challenges
November 16, 2022 | finanznachrichten.de
EV Biologics Corporation: EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX
November 14, 2022 | finance.yahoo.com
EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX
See More Headlines
Receive YECO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EV Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/11/2023
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Concrete, gypsum, & plaster products
Sub-Industry
N/A
Sector
Construction
Current Symbol
OTCMKTS:YECO
CUSIP
N/A
CIK
1607741
Web
www.evbiologics.com
Phone
(518) 638-8192
Fax
N/A
Employees
284
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,230,000
Free Float
6,006,000
Market Cap
$10.13 million
Optionable
Not Optionable
Beta
0.05
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Daniel S. McKinney (Age 61)
    Founder, Chairman & CEO
  • Mr. Monte Fisher
    Chief Financial Officer
  • Mr. William Bossung
    Corporate Finance Director & Corporate Secretary

Key Competitors

View All Competitors














YECO Stock Analysis - Frequently Asked Questions

How have YECO shares performed in 2023?

EV Biologics' stock was trading at $1.70 at the beginning of 2023. Since then, YECO stock has decreased by 41.8% and is now trading at $0.99.
View the best growth stocks for 2023 here.

Are investors shorting EV Biologics?

EV Biologics saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,900 shares, a decline of 17.4% from the October 31st total of 2,300 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is currently 6.3 days.
View EV Biologics' Short Interest.

How do I buy shares of EV Biologics?

Shares of YECO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:YECO) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -